Delivery Order SPE2DB24D1007-SPE2DB24FBZUN

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $1,214.70 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 30, 2024. The contract has an ultimate completion date of September 3, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $3,972.90 and an ultimate completion date of January 25, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $3,219.78 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 21, 2022, with a completion date of November 22, 2022. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of Trulicity 3 mg/0.5 ml pens to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $3,201.82, is a firm fixed-price delivery order with a completion date of June 7, 2024. The award is not associated with a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation, has a significant Indefinite...
This federal contract award is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $3,048.48 firm fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a March 11, 2024 completion date and was not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 mL pens to the Defense Logistics Agency (DLA). The $1,451.40 firm-fixed-price delivery order was awarded to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 2, 2024 and was awarded on July 1, 2024. There is no set-aside designation for this contract. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $2,801.68 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of November 8, 2022 and was awarded on November 7, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Trulicity 3 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $3,483.36 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 17, 2024. The contract has an ultimate completion date of October 18, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $5,225.04 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of September 18, 2024. The contract is not set-aside and serves as a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 between Amerisourcebergen...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $5,264.46 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB24FBZUN
    Delivery Order

This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $3,047.94 firm fixed price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of July 3, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 10/1/24, 12:32 PM